Jpmorgan Chase & CO Roivant Sciences Ltd. Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 807,765 shares of ROIV stock, worth $9.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
807,765
Previous 768,489 5.11%
Holding current value
$9.21 Million
Previous $9.09 Million 10.35%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$10.09 - $12.08 $396,294 - $474,454
39,276 Added 5.11%
807,765 $8.15 Million
Q4 2024

Feb 12, 2025
SELL
$11.16 - $12.71 $603,677 - $687,522
-54,093 Reduced 6.58%
768,489 $9.09 Million
Q3 2024

Dec 26, 2024
BUY
$10.17 - $12.5 $350,387 - $430,662
34,453 Added 4.37%
822,582 $9.49 Million
Q3 2024

Nov 08, 2024
BUY
$10.17 - $12.5 $350,387 - $430,662
34,453 Added 4.37%
822,582 $9.49 Million
Q2 2024

Dec 26, 2024
SELL
$10.36 - $11.74 $356,933 - $404,478
-34,453 Reduced 4.19%
788,129 $8.33 Million
Q2 2024

Aug 12, 2024
SELL
$10.36 - $11.74 $1.41 Million - $1.59 Million
-135,673 Reduced 14.69%
788,129 $8.33 Million
Q1 2024

Dec 26, 2024
BUY
$9.87 - $11.8 $999,041 - $1.19 Million
101,220 Added 12.31%
923,802 $9.74 Million
Q1 2024

May 10, 2024
BUY
$9.87 - $11.8 $4.95 Million - $5.92 Million
501,362 Added 118.68%
923,802 $9.74 Million
Q4 2023

Dec 26, 2024
SELL
$8.38 - $11.58 $3.35 Million - $4.63 Million
-400,142 Reduced 48.64%
422,440 $4.74 Million
Q4 2023

Feb 12, 2024
SELL
$8.38 - $11.58 $1.23 Million - $1.7 Million
-146,680 Reduced 25.77%
422,440 $4.74 Million
Q3 2023

Nov 14, 2023
BUY
$9.76 - $13.19 $2.33 Million - $3.14 Million
238,303 Added 72.03%
569,120 $6.65 Million
Q2 2023

Aug 11, 2023
SELL
$7.09 - $10.08 $70,481 - $100,205
-9,941 Reduced 2.92%
330,817 $3.33 Million
Q1 2023

May 18, 2023
BUY
$6.92 - $9.98 $373,673 - $538,910
53,999 Added 18.83%
340,758 $2.51 Million
Q1 2023

May 11, 2023
BUY
$6.92 - $9.98 $1.47 Million - $2.12 Million
212,465 Added 285.98%
286,759 $2.12 Million
Q4 2022

Feb 13, 2023
BUY
$3.36 - $7.99 $112,674 - $267,936
33,534 Added 82.27%
74,294 $593,000
Q3 2022

Nov 14, 2022
BUY
$0.51 - $4.84 $1,461 - $13,871
2,866 Added 7.56%
40,760 $131,000
Q2 2022

Aug 11, 2022
BUY
$2.81 - $4.84 $106,482 - $183,406
37,894 New
37,894 $154,000

Others Institutions Holding ROIV

# of Institutions
337
Shares Held
495M
Call Options Held
3.67M
Put Options Held
754K
View Full List

About Roivant Sciences Ltd.

ROIV Quotes by TradingView
  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.03B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email